Kenvue Announces Participation in Deutsche Bank's dbAccess Global Consumer Conference

Audio By Carbonatix

SUMMIT, N.J.--(BUSINESS WIRE)--May 21, 2025--

Kenvue Inc. (NYSE: KVUE), the maker of iconic brands such as Neutrogena®, Listerine®, Aveeno®, and Tylenol®, today announced the Company’s participation in Deutsche Bank’s dbAccess Global Consumer Conference in Paris, France. Thibaut Mongon, Chief Executive Officer, Amit Banati, Chief Financial Officer, and Carlton Lawson, Group President, Europe, Middle East and Africa & Latin America will participate in a fireside chat on Tuesday, June 3, 2025, at 6:00 a.m. Eastern Time / 12:00 p.m. Central European Time. A live webcast of the session will be available on investors.kenvue.com and a replay will be available on the website following the event.

About Kenvue

Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno ®, BAND-AID ® Brand, Johnson’s ®, Listerine ®, Neutrogena ® and Tylenol ®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250521562833/en/

CONTACT: Investor Relations:

Sofya Tsinis

[email protected] Relations:

Melissa Witt

[email protected]

KEYWORD: EUROPE UNITED STATES NORTH AMERICA FRANCE NEW JERSEY

INDUSTRY KEYWORD: COSMETICS MEDICAL SUPPLIES RETAIL HEALTH GENERAL HEALTH PHARMACEUTICAL

SOURCE: Kenvue

Copyright Business Wire 2025.

PUB: 05/21/2025 06:45 AM/DISC: 05/21/2025 06:44 AM

http://www.businesswire.com/news/home/20250521562833/en